Rezolute (RZLT) Short term Debt (2011 - 2021)
Rezolute recorded quarterly Short term Debt of $1.8 million in Q1 2021, up 2007677.78% quarter-over-quarter from $90.0 in Q4 2017.
Rezolute's Short term Debt history runs 8 years deep, the most recent figure standing at $1.8 million for Q1 2021.
- In Q1 2021, Short term Debt changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2021 stood at $1.8 million (changed N/A YoY), while the FY2017 annual figure was $588.0, down 95.08% from the prior year.
- Short term Debt came in at $1.8 million for Q1 2021 at Rezolute, up from $90.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.8 million in Q1 2021 to a low of $90.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1.81 Mn |
| Dec 31, 2017 | 90.00 |
| Sep 30, 2017 | 246.00 |
| Jun 30, 2017 | 588.00 |
| Mar 31, 2017 | 438.00 |
| Dec 31, 2016 | 1,230.00 |
| Sep 30, 2016 | 2,543.00 |
| Jun 30, 2016 | 11,955.00 |
| Mar 31, 2016 | 11,679.00 |
| Dec 31, 2015 | 17,461.00 |
| Sep 30, 2015 | 19,190.00 |
| Jun 30, 2015 | 31,777.00 |
| Dec 31, 2014 | 1.07 Mn |
| Sep 30, 2014 | 381,806.00 |
| Jun 30, 2014 | 35,595.00 |
| Mar 31, 2014 | 1.12 Mn |
| Dec 31, 2013 | 1.07 Mn |
| Sep 30, 2013 | 953,701.00 |
| Jun 30, 2013 | 157,761.00 |
| Mar 31, 2013 | 522,893.00 |
| Dec 31, 2012 | 15,868.00 |
| Dec 31, 2011 | 2,140.00 |